Industry supports EU effort to boost vaccination rates

8 November 2018
2019_biotech_test_vial_discovery_big

Vaccines Europe, a trade group representing vaccines manufacturers in Europe, warns that vaccines have become “a victim of their own success,” as the absence of severe diseases has created a perception that vaccination is no longer necessary.

Writing in a blog post, the group’s president, Pascale Mauran, provided his view on a proposal to convene a new coalition for vaccination bringing together European associations of healthcare workers, with the aim of increasing vaccination coverage in Europe.

Outbreaks of preventable diseases such as measles in Italy, Germany and other parts of Europe have exacerbated concerns about flagging vaccination rates.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology